Save time and resources during the development of mammalian cell lines with ClonaCell™ specialized cloning media. Semi-solid cloning with ClonaCell™ methylcellulose-based media is a superior cloning method that allows you to overcome the challenges of using traditional limiting dilution cloning for developing mammalian cell lines. ClonaCell™ media streamlines your cell line development workflow by achieving a high probability of monoclonality, high clonal diversity and increased cloning efficiency in a single cloning step. STEMCELL Technologies provides ClonaCell™ products for cloning CHO cells and hybridomas, including animal component-free, chemically-defined and pre-screened serum-containing formulations. With uncompromising quality, innovative cloning techniques and technology for automated cell line development, ClonaCell™ products help you to take the smart way to the right clone.
Semi-Solid Cloning with ClonaCell™ Saves Time and Resources
Semi-solid cloning with ClonaCell™ methylcellulose-based media achieves a high probability of monoclonality through separation of individual cells by suspension in semi-solid cell culture media. Separated cells grow into discrete, monoclonal colonies that can be easily isolated manually or robotically. Semi-solid cloning increases the probability of monoclonality, decreases the number of cloning steps and decreases the resources expended on the development of mammalian cell lines.
ClonaCell™-CHO Products Streamline CHO Cell Line Development
ClonaCell™-HY is a Complete System for Hybridoma Generation
ClonaCell™-HY products provide a complete cell culture media solution for hybridoma cell line development. We offer a complete kit including media and reagents for pre-fusion culture, fusion, recovery, HAT selection, cloning and hybridoma expansion. Also available are cloning and expansion media for other selection systems.
ClonaCell™ EasyPick Provides Automated Solutions for Cell Line Development
The ClonaCell™ EasyPick, produced in partnership with HAMILTON Robotics, is a fully automated platform for developing mammalian cell lines with semi-solid cloning.